Point-of-Care Ultrasound Is the Quiet Revolution in Diagnostics
Dr. Dereck Mush, MD, MBA
What they do
VUNO develops deep learning diagnostic tools that analyze medical images, pathology slides, and patient biosignals. Its software assists clinicians in identifying abnormalities in chest radiographs, fundus images, and bone age scans, enhancing diagnostic precision and efficiency.
The record
- Vertical
- Imaging & Diagnostics
- Sub-segment
- Medical AI diagnostics
- Product type
- Software as a medical device
- Stage
- Public
- Headquarters
- Seoul, South Korea
- Region
- Asia-Pacific
- Founded
- 2014
- Total funding
- $20M raised
Notable investors: HB Investment, SBI Investment, Green Cross Holdings.
Also in Imaging & Diagnostics
Related on The Signal
Dr. Dereck Mush, MD, MBA
Mobile Optical Diagnostics: Ending the Multibillion-Dollar Emergency Vertigo Workup
Dr. Dereck Mush, MD, MBAThe HealthTech Signal
The 8 Best AI Diagnostic Tools of 2026
AI diagnostics stopped being experimental. These eight tools are FDA-cleared, deployed at scale, and quietly changing how disease gets found.
Dr. Dereck Mush, MD, MBA
Decentralizing Syndromic PCR: The Point-of-Care Molecular Margin War
Dr. Dereck Mush, MD, MBA